A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms

References

• Alvarenga LS, Mannis MJ. Ocular rosacea. Ocul Surf 2005;3:41–58.
   PubMed Web of Science ®Google Scholar
• Viso E, Millan CE, Rodríguez-Ares TM. Rosacea-associated meibomian gland dysfunction – an epidemiological perspective. Eur Ophthalmic Rev 2014;8(1):13–16.
   Google Scholar
• Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003;22:230–233.
   PubMed Web of Science ®Google Scholar
• Patiño-Rodríguez BE, Rodríguez-García A, Díaz JC. External ocular surface changes in ocular rosacea patients. Rev Mex Oftalmol 2012;86:86–96.
   Google Scholar
• Arman A, Demirseren DD, Takmaz T. Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline. Int J Ophthalmol 2015;8(3):544–549.
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001;42(10):2283–2292.
   PubMed Web of Science ®Google Scholar
• Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40(11):2506–2512.
   PubMed Web of Science ®Google Scholar
• Stone DU, Chodosh J. Oral tetracyclines for ocular rosacea: an evidence-based review of the literature. Cornea 2004;23:106–109.
   PubMed Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001;36:1007–1024. Review.
   Google Scholar
• Hampel U, Kruger M, Kunnen C, Garreis F, Wilcox M, Paulsen F. In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells. Exp Eye Res 2015. doi:10.1016/j.exer.2015.08.024.
   PubMed Web of Science ®Google Scholar
• Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008;126(2):219–225.
   PubMedGoogle Scholar
• Desbois AP, Lawlor KC. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus. Mar Drugs 2013;11:4544–4557.
   PubMed Web of Science ®Google Scholar
• Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002;46:584–587. Comment in: J Am Acad Dermatol 2004;51: 327–341; quiz 342–344.
   Google Scholar
• Bhargava R, Kumar P, Phogat H, Kaur A, Kumar M. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Cont Lens Anterior Eye 2015;38:206–210.
   PubMed Web of Science ®Google Scholar
• Kumar P, Bhargava R, Kumar M, Ranjan S, Kumar M, Verma P. The correlation of routine tear function tests and conjunctival impression cytology in dry eye syndrome. Korean J Ophthalmol 2014;28:122–129.
   PubMedGoogle Scholar
• Bhargava R, Kumar P. Oral omega-3 fatty acid treatment for dry eye in contact lens wearers. Cornea 2015;34:413–420.
   PubMed Web of Science ®Google Scholar
• Bhargava R, Kumar P, Kaur A, Kumar M, Mishra A. The diagnostic value and accuracy of conjunctival impression cytology, dry eye symptomatology, and routine tear function tests in computer users. J Lab Phys 2014;6:102–108.
   Google Scholar
• Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011;52:2006–2049.
   PubMed Web of Science ®Google Scholar
• Unlü C, Güney E, Akçay Bİ, Akçalı G, Erdoğan G, Bayramlar H. Comparison of ocular-surface disease index questionnaire, tear film break-up time, and Schirmer tests for the evaluation of the tear film in computer users with and without dry-eye symptomatology. Clin Ophthalmol 2012;6:1303–1306.
   PubMedGoogle Scholar
• Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004;23:272–285.
   PubMed Web of Science ®Google Scholar
• Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol 2008;2:31–55.
   PubMedGoogle Scholar
• Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A. A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol 2013;6:811–816.
   PubMed Web of Science ®Google Scholar
• Liu A, Ji J. Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Med Sci Monit 2014;20:1583–1589.
   PubMed Web of Science ®Google Scholar
• Oleñik A, Jiménez-Alfaro I, Alejandre-Alba N, Mahillo-Fernández I. A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interventions Aging 2013;8:1133–1138.
   PubMed Web of Science ®Google Scholar
• Spite M, Clària J, Serhan CN. Resolvins, specialized pro-resolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab 2014;19:21–36.
   PubMed Web of Science ®Google Scholar
• Barton K, Monroy DC, Nava A, Pflugfelder SC. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 1997;104:1868–1874.
   PubMed Web of Science ®Google Scholar
• Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 2011;30:308–314.
   PubMed Web of Science ®Google Scholar